EUVIMEDEUVIMED entdecken
Open Access

Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs

Pragya Kakani, David M Cutler, Meredith B Rosenthal, Nancy L Keating

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2023.56592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Pragya Kakani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, Weill Cornell Medical College, New York, New York. Hauptthemen laut MEDLINE: Pharmacies, Physicians, Communicable Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Increasing integration across medical services may have important implications for health care quality and spending. One major but poorly understood dimension of integration is between physician organizations and pharmacies for self-administered drugs or in-house pharmacies.

Objective

To describe trends in the use of in-house pharmacies, associated physician organization characteristics, and associated drug prices. Design, Setting, and Participants A cross-sectional study was conducted from calendar years 2011 to 2019. Participants included 20% of beneficiaries enrolled in fee-for-service Medicare Parts A, B, and D. Data analysis was performed from September 15, 2020, to December 20, 2023. Exposures Prescriptions filled by in-house pharmacies. Main Outcomes and Measures The share of Medicare Part D spending filled by in-house pharmacies by drug class, costliness, and specialty was evaluated. Growth in the number of physician organizations and physicians in organizations with in-house pharmacies was measured in 5 specialties: medical oncology, urology, infectious disease, gastroenterology, and rheumatology. Characteristics of physician organizations with in-house pharmacies and drug prices at in-house vs other pharmacies are described.

Results

Among 8 020 652 patients (median age, 72 [IQR, 66-81] years; 4 570 114 [57.0%] women), there was substantial growth in the share of Medicare Part D spending on high-cost drugs filled at in-house pharmacies from 2011 to 2019, including oral anticancer treatments (from 10% to 34%), antivirals (from 12% to 20%), and immunosuppressants (from 2% to 9%). By 2019, 63% of medical oncologists, 20% of urologists, 29% of infectious disease specialists, 21% of gastroenterologists, and 22% of rheumatologists were in organizations with specialty-relevant in-house pharmacies. Larger organizations had a greater likelihood of having an in-house pharmacy (0.75 percentage point increase [95% CI, 0.56-0.94] per each additional physician), as did organizations owning hospitals enrolled in the 340B Drug Discount Program (10.91 percentage point increased likelihood [95% CI, 6.33-15.48]). Point-of-sale prices for high-cost drugs were 1.76% [95% CI, 1.66%-1.87%] lower at in-house vs other pharmacies. Conclusions and Relevance In this cross-sectional study of physician organization–operated pharmacies, in-house pharmacies were increasingly used from 2011 to 2019, especially for high-cost drugs, potentially associated with organizations’ financial incentives. In-house pharmacies offered high-cost drugs at lower prices, in contrast to findings of integration in other contexts, but their growth highlights a need to understand implications for patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmaciesPhysiciansCommunicable DiseasesUnited StatesHumansAgedFemaleMaleCross-Sectional StudiesMedicare

Autor:innen und Institutionen

  • Department of Population Health Sciences, Weill Cornell Medical College, New York, New York.
  • Department of Economics, Harvard University, Cambridge, Massachusetts.
  • National Bureau of Economic Research, Cambridge, Massachusetts.
  • Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
  • Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Förderung

  • AHRQ HHS
  • NIA NIH HHS

Zitieren

APA

Kakani, P., Cutler, D. M., Rosenthal, M. B., & Keating, N. L. (2024). Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.56592

Vancouver

Kakani P, Cutler DM, Rosenthal MB, Keating NL. Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2023.56592

BibTeX
@article{Kakani2024,
  author = {Kakani, Pragya and Cutler, David M and Rosenthal, Meredith B and Keating, Nancy L},
  title = {Trends in Integration Between Physician Organizations and Pharmacies for Self-Administered Drugs},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2023.56592}
}
Kostenlos starten →